A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis

Clinical trial NCT01532869 · COMPLETED

Trial details

NCT number: NCT01532869
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sclerosis, Systemic

Start date: 2012-03-01
Primary completion: 2014-01-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.